NO146457C - Fremgangsmaate for fremstilling av en solubilisert og stabilisert parenteral opploesning som inneholder 2-klor-11-(4-metyl-1-piperazinyl)-dibenz(b,f)(1,4)oksazepin - Google Patents

Fremgangsmaate for fremstilling av en solubilisert og stabilisert parenteral opploesning som inneholder 2-klor-11-(4-metyl-1-piperazinyl)-dibenz(b,f)(1,4)oksazepin

Info

Publication number
NO146457C
NO146457C NO762713A NO762713A NO146457C NO 146457 C NO146457 C NO 146457C NO 762713 A NO762713 A NO 762713A NO 762713 A NO762713 A NO 762713A NO 146457 C NO146457 C NO 146457C
Authority
NO
Norway
Prior art keywords
ocsazepine
dibenz
solubilized
piperazinyl
chloro
Prior art date
Application number
NO762713A
Other languages
English (en)
Norwegian (no)
Other versions
NO762713L (fr
NO146457B (no
Inventor
Bruce Edwin Haeger
James Elwood Krueger
James Alfred Lowery
Lawrence Ritter
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO762713L publication Critical patent/NO762713L/no
Publication of NO146457B publication Critical patent/NO146457B/no
Publication of NO146457C publication Critical patent/NO146457C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO762713A 1975-08-06 1976-08-05 Fremgangsmaate for fremstilling av en solubilisert og stabilisert parenteral opploesning som inneholder 2-klor-11-(4-metyl-1-piperazinyl)-dibenz(b,f)(1,4)oksazepin NO146457C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60233175A 1975-08-06 1975-08-06

Publications (3)

Publication Number Publication Date
NO762713L NO762713L (fr) 1977-02-08
NO146457B NO146457B (no) 1982-06-28
NO146457C true NO146457C (no) 1982-10-06

Family

ID=24410918

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762713A NO146457C (no) 1975-08-06 1976-08-05 Fremgangsmaate for fremstilling av en solubilisert og stabilisert parenteral opploesning som inneholder 2-klor-11-(4-metyl-1-piperazinyl)-dibenz(b,f)(1,4)oksazepin

Country Status (19)

Country Link
JP (1) JPS5221313A (fr)
AR (1) AR210501A1 (fr)
AT (1) AT345464B (fr)
AU (1) AU500641B2 (fr)
BE (1) BE844903A (fr)
CA (1) CA1069823A (fr)
DE (1) DE2633943A1 (fr)
DK (1) DK147727C (fr)
EG (1) EG12425A (fr)
ES (1) ES450520A1 (fr)
FI (1) FI762171A (fr)
FR (1) FR2320102A1 (fr)
GB (1) GB1546933A (fr)
IL (1) IL49996A (fr)
NL (1) NL7608575A (fr)
NO (1) NO146457C (fr)
PT (1) PT65400B (fr)
SE (1) SE431716B (fr)
ZA (1) ZA764052B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
FR2739254B1 (fr) * 1995-09-29 1997-12-19 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
WO2010106325A2 (fr) 2009-03-18 2010-09-23 Omnipharm Limited Formulation parasiticide

Also Published As

Publication number Publication date
ES450520A1 (es) 1978-05-01
AT345464B (de) 1978-09-25
ATA581376A (de) 1978-01-15
DK147727B (da) 1984-11-26
PT65400A (en) 1976-08-01
NO762713L (fr) 1977-02-08
AR210501A1 (es) 1977-08-15
PT65400B (en) 1978-01-27
EG12425A (en) 1979-06-30
BE844903A (fr) 1977-02-07
SE431716B (sv) 1984-02-27
ZA764052B (en) 1977-06-29
FR2320102A1 (fr) 1977-03-04
NO146457B (no) 1982-06-28
IL49996A0 (en) 1976-09-30
SE7608810L (sv) 1977-02-07
AU500641B2 (en) 1979-05-31
IL49996A (en) 1981-01-30
DK147727C (da) 1985-06-17
GB1546933A (en) 1979-05-31
DK354076A (da) 1977-02-07
FI762171A (fr) 1977-02-07
CA1069823A (fr) 1980-01-15
DE2633943A1 (de) 1977-02-17
NL7608575A (nl) 1977-02-08
JPS5221313A (en) 1977-02-17
AU1577576A (en) 1978-01-12

Similar Documents

Publication Publication Date Title
KE3146A (en) 1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizine derivatives
ZA776900B (en) N,n'-methylenebis-(o,o-diaryl n-phosphono-methylglycinonitriles)
EG13910A (en) 1,3,4 substituted parazoline derivatives
GB1524917A (en) Gona-1,9(10)-dienes
GB1542361A (en) 1,4-benzo-dioxan derivatives
GB1548222A (en) Trans-4-heterocyclyl-3,4-dihydro-2h-benzo pyarn-3-ol derivatives
NO146457C (no) Fremgangsmaate for fremstilling av en solubilisert og stabilisert parenteral opploesning som inneholder 2-klor-11-(4-metyl-1-piperazinyl)-dibenz(b,f)(1,4)oksazepin
NZ185962A (en) Stabilisation of 1,1,1-tricholorethane
KE3289A (en) 1,4-dioxido-3-methyl-quinoxaline(2)carboxamides
AU2508677A (en) 5,6-dihydro-prostacyclin analogs
GB1550440A (en) 1,3,4-oxadiazole derivatives
NO774503L (no) Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
GB1543807A (en) 1,2,3,4,6,7,12,12b-octahydro-1,12-methanooxymethano-indolo(2,3-o)quinolizines
NZ185419A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-ones
GB2062628B (en) 1,2,4-oxadiazine derivatives
AU511827B2 (en) 5-anyl-3, 6-dihydro-l, 3, 4-oxadiazin-2-ones
IL51317A0 (en) 1,3-dihydro-1'-dimethylphosphinylalkyl-3-phenylspiro (isobenzofurans)
USD241667S (en)
AU496237B2 (en) 1-acyl-2-(8-chloro-10, 11-dihydrodibenz-(b,f) (1,4) oxazepine-10-carbonylohydrazines
GB1544339A (en) 2,3-dihydro-2-oxo-3-benzo(b)thiophenecarboxamides
GB1556249A (en) 1'h-androsta(16,17)cyclopentene-3'-ones
ZA777214B (en) Tetrahydro-1,3,5-oxadiazin-4-one derivatives
NZ186313A (en) 5-phenylthieno (2,3-e)(4,')oxazepine derivatives
GB1544998A (en) 1,4-benzodiazepine derivatives